Thank you for visiting the mAb Colorado Website!

On this website you will find the archive of products and research findings from the mAb Colorado project. However, as of May 2022 only the "Research" tab will be updated. Please contact your healthcare provider if you are trying to find monoclonal antibody treatment for COVID-19.


Published mAb Colorado RWE and D&I Findings

mAb RWE Published Manuscripts

Real-world use of Nirmatrelvir-Ritonavir in Outpatients with COVID-19 During the Era of Omicron Variants Including BA.4 and BA.5 in Colorado, USA: a Retrospective Cohort Study

mAb D&I Published Manuscripts

Real-world use of Nirmatrelvir-Ritonavir in Outpatients with COVID-19 During the Era of Omicron Variants Including BA.4 and BA.5 in Colorado, USA: a Retrospective Cohort Study

 

This project was funded by a grant from the National Institutes of Health (NIH) and National Center for Advancing Translational Sciences (NCATS) (award number UL1-TR002535-03S3).

Colorado Clinical and Translational Sciences Institute (CCTSI)

CU Anschutz

Leprino Building

12401 East 17th Avenue

3rd Floor

Aurora, CO 80045


CMS Login